Qualigen Therapeutics, Inc. - stock earnings

QLGN Quarterly earnings

DateEarningsRevenue
2023Q3 -3.7 million USD ? USD
2023Q2 -3.5 million USD 1.6 million USD
2023Q1 -8.5 million USD 1.4 million USD
2022Q4 -6.4 million USD 1.4 million USD
2022Q3 -3.8 million USD 1.4 million USD
2022Q2 -4.1 million USD 1.4 million USD
2022Q1 -4.3 million USD 722029 USD
2021Q4 -6.1 million USD 1.5 million USD
2021Q3 -2.9 million USD 1.2 million USD
2021Q2 -5.3 million USD 1.1 million USD
2021Q1 -3.7 million USD 1.9 million USD
2020Q4 8.8 million USD 1.1 million USD
2020Q3 -8.1 million USD 837714 USD
2020Q2 -18.6 million USD 904067 USD
2020Q1 -1.7 million USD ? USD
2019Q4 -10.1 trillion USD -2.7 million USD
2019Q3 -356225 USD 1.2 million USD
2019Q2 -594565 USD 1.5 million USD
2019Q1 -6.6 million USD ? USD
2018Q3 -4.6 million USD ? USD
2018Q2 -3.6 million USD ? USD
2018Q1 -2.0 million USD ? USD
2017Q4 -2.2 million USD ? USD
2017Q3 -2.0 million USD ? USD
2017Q2 -2.0 million USD ? USD
2017Q1 -1.7 million USD ? USD
2016Q4 -7.6 million USD ? USD
2016Q3 -3.5 million USD ? USD
2016Q2 -4.1 million USD ? USD
2016Q1 -3.1 million USD ? USD
2015Q3 -3.1 million USD ? USD
2015Q2 -2.1 million USD ? USD

QLGN Yearly earnings

DateEarningsRevenue
2023 -17.3 million USD 5.0 million USD
2022 -21.0 million USD 5.0 million USD
2021 -17.9 million USD 5.7 million USD
2020 -20.4 million USD 4.3 million USD
2019 -10.1 trillion USD 5.6 million USD
2018 -16.9 million USD 5.8 million USD
2017 -7.9 million USD ? USD
2016 -18.4 million USD ? USD
2015 -9.2 million USD ? USD

QLGN

Price: $0.30

52 week price:
0.29
1.26

Earnings Per Share: -4.07 USD

P/E Ratio: -0.13

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 69100

Market Capitalization: 1.9 million

Links: